Skip to main content

People in the News: Jul 30, 2010 (rev. 1)


On July 19, Paul Burrin resigned as senior vice president and chief marketing officer of Accelrys.

Under the terms of his separation agreement with the company, Burrin will receive a total severance pay of $142,500 over six months and will be eligible for reimbursement of COBRA medical insurance payments for up to six months beginning Aug. 1.

Burrin will also be eligible to receive an undisclosed bonus for the first quarter of the 2011 fiscal year.

GenomeQuest has appointed Anthony Flynn as its chief marketing officer.

Before joining GenomeQuest, Flynn was a CMO at Bentley Systems, a provider of engineering software, and also worked as a marketing management for two startups in electronic design automation.

Flynn plans to launch a campaign showcasing GenomeQuest's ability to provide whole- and multi-genome analysis using the GenomeQuest sequence database engine, which lets users compare and manage genomic sequence databases.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.